You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

BYDUREON

Showing 1 - 25 of 59
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cocaine Use Disorder Trial in Houston (Exenatide 2 mg [Bydureon], Drug Counseling)

Completed
Has Results
  • Cocaine Use Disorder
  • Exenatide 2 mg [Bydureon]
  • Drug Counseling
  • Houston, Texas
    UTHealth Behavioral and Biomedical Sciences Building
May 31, 2022

Obesity Trial in Salzburg, Uppsala (Exenatide, Placebo)

Completed
  • Obesity
  • Salzburg, Austria
  • +1 more
May 17, 2022

Severe Obesity Trial in Minneapolis (Weight loss with pharmacotherapy, Weight loss without pharmacotherapy)

Completed
Has Results
  • Severe Obesity
  • Weight loss with pharmacotherapy
  • Weight loss without pharmacotherapy
  • Minneapolis, Minnesota
    University of Minnesota
Dec 1, 2021

A Pan-European Post-Authorisation Safety Study: Risk of

Not yet recruiting
  • Pancreatic Cancer
  • Exenatide
  • Non-GLP-1 RA based glucose lowering drugs
  • (no location specified)
Dec 21, 2022

Atherosclerosis, Diabetes, Restenosis Trial in Stockholm (Bydureon, Humulin kwickpen, Metformin)

Recruiting
  • Atherosclerosis
  • +2 more
  • Bydureon
  • +2 more
  • Stockholm, Other, Sweden
    Dept of clinical science and education Karolinska Institutet Söd
Aug 31, 2021

Childhood Obesity Trial in Seattle (Family Based Behavioral Treatment, Exenatide 2 mg [Bydureon], Placebo)

Recruiting
  • Childhood Obesity
  • Family Based Behavioral Treatment
  • +2 more
  • Seattle, Washington
    Seattle Children's Hospital
Aug 30, 2021

Parkinson's Disease Trial in Gainesville (Exenatide)

Completed
  • Parkinson's Disease
  • Gainesville, Florida
    Laboratory for Rehabilitation Neuroscience
Sep 14, 2022

Type 2 Diabetes Trial (NPM-119 (exenatide implant), Bydureon BCise (exenatide extended release))

Not yet recruiting
  • Type 2 Diabetes
  • NPM-119 (exenatide implant)
  • Bydureon BCise (exenatide extended release)
  • (no location specified)
Jan 29, 2023

Diabetes, Type 2 Trial in Shavano Park (Exenatide 2 MG, Dapagliflozin 10 MG)

Completed
  • Diabetes Mellitus, Type 2
  • Exenatide 2 MG
  • Dapagliflozin 10 MG
  • Shavano Park, Texas
    Consano Clinical Research, LLC
Aug 24, 2021

Smoking Cessation, Weight Gain Trial in Houston (Exenatide 2 milligram (mg) Injection, Placebo, Nicotine patch)

Not yet recruiting
  • Smoking Cessation
  • Weight Gain
  • Exenatide 2 milligram (mg) Injection
  • +3 more
  • Houston, Texas
    The University of Texas Health Science Center at Houston
Nov 2, 2022

Cerebral Small Vessel Disease Trial in Hong Kong (Exenatide extended release)

Recruiting
  • Cerebral Small Vessel Disease
  • Exenatide extended release
  • Hong Kong, Hong Kong
    Chinese University of Hong Kong
Jul 18, 2022

Diabetes, Type 2 Trial in San Antonio (Dapagliflozin, Exenatide, Placebo)

Active, not recruiting
  • Diabetes Mellitus, Type 2
  • San Antonio, Texas
    University of Texas Health Science Center
Sep 12, 2022

Parkinson's Disease Trial in London (Exenatide extended release 2mg (Bydureon))

Active, not recruiting
  • Parkinson's Disease
  • Exenatide extended release 2mg (Bydureon)
  • London, United Kingdom
    University College London Hospital
May 18, 2022

Schizophrenia, Schizoaffective Disorder Trial in Worcester (Exenatide, Placebo)

Completed
Has Results
  • Schizophrenia
  • Schizoaffective Disorder
  • Worcester, Massachusetts
    UMass Medical School
Jan 4, 2022

Diabetes, Type 2 Trial in San Antonio (Placebo, Exenatide, Dapagliflozin)

Active, not recruiting
  • Diabetes Mellitus, Type 2
  • Placebo
  • +3 more
  • San Antonio, Texas
    University Health System Texas Diabetic Institute
Apr 28, 2022

Diabetes, Type 1, Hypoglycemia, Autoimmune Diseases Trial in Miami (Anti-Thymocyte Globulin (ATG), Interleukin 2, Exenatide)

Not yet recruiting
  • Diabetes Mellitus, Type 1
  • +3 more
  • Anti-Thymocyte Globulin (ATG)
  • +7 more
  • Miami, Florida
    Diabetes Research Institute, University of Miami Miller School o
Feb 23, 2022

Dysglycemia, Cognitive Deficit Trial in Parma (Exenatide, )

Active, not recruiting
  • Dysglycemia
  • Cognitive Deficit
  • Parma, Italy
  • +1 more
Aug 10, 2021

Alcohol Dependence, in Remission, Addiction, Alcohol Trial in Copenhagen (Exenatide 2 MG Injection, BD PosiFlush (saline))

Completed
  • Alcohol Dependence, in Remission
  • Addiction, Alcohol
  • Exenatide 2 MG Injection
  • BD PosiFlush (saline)
  • Copenhagen, Frederiksberg, Denmark
    Novavì ambulatorierne
Jun 3, 2021

Obesity Trial in Changsha (Liraglutide, Exenatide, Exenatide Microspheres for Injection)

Recruiting
  • Obesity
  • Changsha, Hunan, China
    Xiangya Hospital of Central South University
Apr 7, 2021

Polycystic Ovary Syndrome, Obesity Trial in Baton Rouge (Exenatide once weekly (EQW ), Dapagliflozin (DAPA), EQW plus DAPA)

Completed
Has Results
  • Polycystic Ovary Syndrome
  • Obesity
  • Exenatide once weekly (EQW )
  • +4 more
  • Baton Rouge, Louisiana
    Woman's Hospital
Jan 9, 2021

Smoking Cessation Trial in Houston (Exenatide, NRT, Counseling)

Completed
Has Results
  • Smoking Cessation
  • Houston, Texas
    The University of Texas Health Science Center at Houston
Jan 26, 2021

Type 2 Diabetes, Incretinomimetics, Pancreas Trial in Brussels (Incretinomimetics, DPP-4 inhibitors)

Recruiting
  • Type 2 Diabetes
  • +2 more
  • Brussels, Belgium
    Gastroenterology Department Erasme Hospital
Mar 1, 2021

Type I Diabetes Trial in United States (Exenatide (Bydureon®), Placebo)

Completed
Has Results
  • Type I Diabetes
  • Exenatide (Bydureon®)
  • Placebo
  • San Francisco, California
  • +7 more
Mar 17, 2020

Type 2 Diabetes, Chronic Kidney Disease, Left Ventricular Diastolic Dysfunction Trial in Dallas (BYDUREON, Placebo)

Completed
  • Type 2 Diabetes Mellitus
  • +2 more
  • BYDUREON
  • Placebo
  • Dallas, Texas
    Baylor Scott and White Research Institute- Baylor Heart and Vasc
Jan 25, 2021

Multiple System Atrophy Trial in London (Exenatide Pen Injector [Bydureon])

Recruiting
  • Multiple System Atrophy
  • Exenatide Pen Injector [Bydureon]
  • London, United Kingdom
    Leonard Wolfson Experimental Neurology Centre, National Hospital
Nov 4, 2020